TWI777833B - Method of predicting chronic kidney disease and system thereof - Google Patents
Method of predicting chronic kidney disease and system thereof Download PDFInfo
- Publication number
- TWI777833B TWI777833B TW110140212A TW110140212A TWI777833B TW I777833 B TWI777833 B TW I777833B TW 110140212 A TW110140212 A TW 110140212A TW 110140212 A TW110140212 A TW 110140212A TW I777833 B TWI777833 B TW I777833B
- Authority
- TW
- Taiwan
- Prior art keywords
- kidney disease
- exhaled
- threshold value
- ammonia concentration
- unit
- Prior art date
Links
Images
Landscapes
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
本發明係有關於一種方法及系統,尤其是指一種慢性腎臟病預測方法及系統。The present invention relates to a method and system, especially a method and system for predicting chronic kidney disease.
慢性腎臟病(Chronic Kidney Disease;CKD)是一個嚴重的公衛問題,不僅僅是在台灣,其全球罹病率也不斷地增加,且通常為不可逆損傷。另外,慢性腎臟病不僅會造成末期腎臟病(End Stage Renal Disease;ESRD),同時也是造成死亡及心血管疾病的重要因子,因此,慢性腎臟病的問題在全球越來越被重視,也因此腎功能的定期檢查是必須的。然而,由於患者對於慢性腎臟病的低認知率、慢性腎臟病的高盛行率,再加上慢性腎臟病的早期並沒有症狀,因此,患者大多不會注意到。而當患者開始出現相關症狀時,往往已經進入慢性腎臟病的中後期。Chronic Kidney Disease (CKD) is a serious public health problem, not just in Taiwan, but with an increasing morbidity and often irreversible damage worldwide. In addition, chronic kidney disease not only causes End Stage Renal Disease (ESRD), but is also an important factor in causing death and cardiovascular disease. Therefore, the problem of chronic kidney disease has been paid more and more attention in the world. Regular checks of functionality are required. However, due to the low awareness rate of patients with chronic kidney disease, the high prevalence of chronic kidney disease, and the absence of symptoms in the early stage of chronic kidney disease, most patients do not notice it. When patients begin to have related symptoms, they often have entered the middle and late stages of chronic kidney disease.
先前技術對於慢性腎臟病的定期檢查,主要是由驗尿、抽血、X光檢查、靜脈注射腎盂攝影術(Intravenous Pyelography;IVP)、電腦斷層攝影(Computed Tomography;CT)、腎臟超音波、腎臟切片等方式,尤其臨床上,都是利用抽血檢驗出血清肌酐酸(serum creatinine)濃度進而利用公式導出估算腎絲球過濾率(estimated Glomerular Filtration Rate;eGFR)。Regular examinations for chronic kidney disease in the prior art mainly include urine tests, blood draws, X-ray examinations, intravenous pyelography (IVP), Computed Tomography (CT), renal ultrasound, renal Slices and other methods, especially clinically, use blood to detect serum creatinine (serum creatinine) concentration and then use formula to derive estimated glomerular filtration rate (estimated Glomerular Filtration Rate; eGFR).
然而,檢查方式過於專業且有侵入性醫療行為,不容易讓患者培養出定期檢查的習慣,且對於醫療資源不普及地區、就醫不便者、抽血有困難者等都極為不便。再者,全球疫情嚴峻,在沒有相關症狀的情況下,患者更不會想前往醫療院所等疫情高風險區域。因此,先前技術存在改善的空間。However, the inspection method is too professional and involves invasive medical behaviors, which makes it difficult for patients to develop the habit of regular inspections, and is extremely inconvenient for areas where medical resources are not widely available, those who are inconvenient to seek medical care, and those who have difficulty in drawing blood. In addition, the global epidemic is severe, and patients will not want to go to high-risk areas such as medical institutions without relevant symptoms. Therefore, there is room for improvement in the prior art.
有鑒於在先前技術中,慢性腎臟病的定期檢查項目過於專業且有侵入性醫療行為不容易讓患者培養出定期檢查的習慣的問題,侵入性醫療行為對於醫療資源不普及地區、就醫不便者、抽血有困難者等都極為不便的問題,以及在疫情嚴峻的情況下患者也不會想前往醫療院所等疫情高風險區域進行相關檢查的問題。本發明之一主要目的係提供一種慢性腎臟病預測方法,用以解決先前技術中的至少一個問題。In view of the problem that in the prior art, the regular examination items for chronic kidney disease are too professional and invasive medical behaviors are not easy for patients to develop the habit of regular examinations. It is extremely inconvenient for people who have difficulty in drawing blood, and the problem that patients do not want to go to high-risk areas such as medical institutions for related examinations under severe epidemic conditions. One of the main objectives of the present invention is to provide a method for predicting chronic kidney disease to solve at least one problem in the prior art.
本發明為解決先前技術之問題,所採用之必要技術手段為提供一種慢性腎臟病預測方法,係包含以下步驟:建立一資料庫,資料庫儲存有一預測規則,且預測規則中係定義出至少一呼氣氨濃度臨界值;獲取一篩檢者之一呼出氣體;感測出呼出氣體之一實測呼氣氨濃度;將實測呼氣氨濃度與呼氣氨濃度臨界值進行比對,當實測呼氣氨濃度大於呼氣氨濃度臨界值時,係判斷符合預測規則,並產生一預警資訊,且預警資訊係代表該篩檢者之一初篩結果為疑似患有慢性腎臟病。In order to solve the problem of the prior art, the necessary technical means adopted by the present invention is to provide a method for predicting chronic kidney disease, which includes the following steps: establishing a database, storing a prediction rule in the database, and defining at least one prediction rule in the prediction rule Threshold value of exhaled ammonia concentration; obtain one of the exhaled air of a screener; sense one of the exhaled air to measure the measured exhaled ammonia concentration; compare the measured exhaled ammonia concentration with the threshold value of exhaled ammonia concentration, When the gas ammonia concentration is greater than the threshold value of the exhaled ammonia concentration, it is judged that the prediction rule is met, and a warning information is generated, and the warning information represents that one of the screening results of the screening person is suspected of having chronic kidney disease.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測方法中之步驟,更包含以下步驟:接收複數個已受測者之複數個已測呼氣氨濃度與複數個腎臟病診斷結果,設定一預設臨界值,將已測呼氣氨濃度與預設臨界值進行比對,而產生複數個腎臟病預測結果;將腎臟病預測結果與腎臟病診斷結果進行比對,藉以統計出以預設臨界值為判斷基準下之一敏感性與一特異性;調整預設臨界值,重複執行上述步驟,直到以預設臨界值為判斷基準下之敏感性與特異性達到一可接受條件時,將預設臨界值定義為呼氣氨濃度臨界值中之一第一臨界值。On the basis of the above-mentioned necessary technical means, a subsidiary technical means derived from the present invention is a step in the method for predicting chronic kidney disease, further comprising the following steps: receiving a plurality of measured breath ammonia concentrations of a plurality of subjects. With a plurality of kidney disease diagnosis results, a preset threshold value is set, the measured exhaled ammonia concentration is compared with the preset threshold value, and multiple kidney disease prediction results are generated; the kidney disease prediction results are compared with the kidney disease diagnosis results. A comparison is performed to obtain a sensitivity and a specificity under the judging benchmark with the preset threshold value; the preset threshold value is adjusted, and the above steps are repeated until the sensitivity and the judging benchmark based on the preset threshold value are When the specificity reaches an acceptable condition, the preset threshold value is defined as a first threshold value among the threshold values of exhaled ammonia concentration.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測方法中之步驟,更包含以下步驟:接收複數個已受測者之複數個已測呼氣氨濃度與複數個腎臟病診斷結果,設定一預設臨界值,將已測呼氣氨濃度與預設臨界值進行比對,而產生複數個腎臟病預測結果;將腎臟病預測結果與腎臟病診斷結果進行比對,藉以統計出以預設臨界值為判斷基準下之一敏感性與一特異性;調整預設臨界值,重複執行上述步驟,直到以複數個上述之預設臨界值為判斷基準下之上述敏感性與上述特異性達到一可接受條件時,將預設臨界值定義出呼氣氨濃度臨界值中之一第一臨界值與一第二臨界值,第一臨界值對應一第一年齡區間,第二臨界值小於第一臨界值並對應一第二年齡區間,且第一年齡區間之一第一年齡下限值係大於第二年齡區間之一第二年齡上限值。On the basis of the above-mentioned necessary technical means, a subsidiary technical means derived from the present invention is a step in the method for predicting chronic kidney disease, further comprising the following steps: receiving a plurality of measured breath ammonia concentrations of a plurality of subjects. With a plurality of kidney disease diagnosis results, a preset threshold value is set, the measured exhaled ammonia concentration is compared with the preset threshold value, and multiple kidney disease prediction results are generated; the kidney disease prediction results are compared with the kidney disease diagnosis results. Carry out a comparison, so as to count a sensitivity and a specificity under the judgment standard with the preset threshold value; adjust the preset threshold value, and repeat the above steps until a plurality of the above-mentioned preset threshold values are under the judgment basis When the above-mentioned sensitivity and above-mentioned specificity reach an acceptable condition, the preset threshold value is defined as a first threshold value and a second threshold value among the threshold values of exhaled ammonia concentration, and the first threshold value corresponds to a first threshold value. In the age interval, the second threshold value is smaller than the first threshold value and corresponds to a second age interval, and a first age lower limit value of the first age interval is greater than a second age upper limit value of the second age interval.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測方法中之步驟,更包含以下步驟:利用一第一管路與一泵浦輸送該呼出氣體至一乾燥筒;利用乾燥筒乾燥呼出氣體;利用一第二管路與泵浦輸送呼出氣體至一容器;利用一容器容置乾燥後之呼出氣體。On the basis of the above necessary technical means, an auxiliary technical means derived from the present invention is a step in the method for predicting chronic kidney disease, further comprising the following steps: using a first pipeline and a pump to transport the exhaled gas to a drying cylinder; drying the exhaled gas by using the drying cylinder; using a second pipeline and a pump to transport the exhaled gas to a container; using a container to hold the exhaled gas after drying.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測方法中之步驟後,更包含以下步驟:利用一第三管路與泵浦將該呼出氣體自容器輸送出。On the basis of the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is to use a third pipeline and a pump after the steps in the method for predicting chronic kidney disease, and further include the following steps: using a third pipeline and a pump to remove the exhaled gas from the container send out.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測方法中之步驟,更包含以下步驟:利用一氨感測模組感測呼出氣體之實測呼氣氨濃度。On the basis of the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is a step in the method for predicting chronic kidney disease, further comprising the following steps: using an ammonia sensing module to sense the measured exhaled ammonia in exhaled air concentration.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測方法,更包含以下步驟:利用一顯示模組顯示預警資訊。On the basis of the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is a method for predicting chronic kidney disease, further comprising the following steps: displaying warning information by using a display module.
本發明為解決先前技術之問題,所採用之必要技術手段為另外提供一種慢性腎臟病預測系統,包含一資料庫、一獲取模組、一氨感測模組、一比較模組與一預警模組。資料庫儲存有一預測規則,且預測規則中係定義出至少一呼氣氨濃度臨界值。獲取模組獲取一篩檢者之一呼出氣體。氨感測模組用以感測呼出氣體之一實測呼氣氨濃度。比較模組電性連接資料庫與氨感測模組,用以比較實測呼氣氨濃度與呼氣氨濃度臨界值,並在實測呼氣氨濃度大於呼氣氨濃度臨界值時,判斷符合預測規則。預警模組電性連接比較模組,用以在符合預測規則時,產生一預警資訊,且預警資訊係代表篩檢者之一初篩結果為疑似患有慢性腎臟病。In order to solve the problems of the prior art, the necessary technical means adopted by the present invention is to provide a chronic kidney disease prediction system, which includes a database, an acquisition module, an ammonia sensing module, a comparison module and an early warning module Group. The database stores a prediction rule, and at least one threshold value of exhaled ammonia concentration is defined in the prediction rule. The acquisition module acquires the exhaled breath of one of the screeners. The ammonia sensing module is used for sensing one of the measured exhaled ammonia concentration in exhaled air. The comparison module is electrically connected to the database and the ammonia sensing module to compare the measured exhaled ammonia concentration and the threshold value of exhaled ammonia concentration, and when the measured exhaled ammonia concentration is greater than the threshold value of exhaled ammonia concentration, it is judged that it is in line with the prediction rule. The early warning module is electrically connected to the comparison module, and is used for generating early warning information when the prediction rule is met, and the early warning information represents that a preliminary screening result of one of the screening persons is suspected of suffering from chronic kidney disease.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測系統,更包含一顯示模組,顯示模組電性連接預警模組,用以顯示預警資訊。On the basis of the above-mentioned necessary technical means, an auxiliary technical means derived from the present invention is that the chronic kidney disease prediction system further includes a display module, which is electrically connected to the early warning module for displaying early warning information.
在上述必要技術手段的基礎下,本發明所衍生之一附屬技術手段為使慢性腎臟病預測系統中之資料庫,係包含一接收單元、一設定單元、一第一比對單元、一第二比對單元、一統計單元、一定義單元與一儲存單元。接收單元用以接收複數個已受測者之複數個已測呼氣氨濃度與複數個腎臟病診斷結果。設定單元用以設定與調整一預設臨界值。第一比對單元電性連接接收單元與設定單元,將已測呼氣氨濃度與預設臨界值進行比對,而產生複數個腎臟病預測結果。第二比對單元電性連接接收單元與第一比對單元,用以將腎臟病預測結果與腎臟病診斷結果進行比對;統計單元電性連接第二比對單元,藉以統計出以預設臨界值為判斷基準下之一敏感性與一特異性。定義單元電性連接統計單元,用以在敏感性與特異性達到一可接受條件時,將預設臨界值定義為預測規則中之呼氣氨濃度臨界值。儲存單元電性連接定義單元,用以儲存該預測規則。On the basis of the above necessary technical means, an auxiliary technical means derived from the present invention is that the database in the chronic kidney disease prediction system includes a receiving unit, a setting unit, a first comparison unit, a second A comparison unit, a statistical unit, a definition unit and a storage unit. The receiving unit is used for receiving a plurality of measured breath ammonia concentrations and a plurality of kidney disease diagnosis results of a plurality of subjects. The setting unit is used for setting and adjusting a preset threshold value. The first comparison unit is electrically connected to the receiving unit and the setting unit, and compares the measured exhaled ammonia concentration with a preset threshold to generate a plurality of kidney disease prediction results. The second comparison unit is electrically connected to the receiving unit and the first comparison unit, and is used to compare the kidney disease prediction result with the kidney disease diagnosis result; the statistics unit is electrically connected to the second comparison unit, so as to calculate the predetermined The critical value is a sensitivity and a specificity under the judgment criteria. The defining unit is electrically connected to the statistical unit, and is used to define the preset threshold as the threshold of exhaled ammonia concentration in the prediction rule when the sensitivity and specificity reach an acceptable condition. The storage unit is electrically connected to the definition unit for storing the prediction rule.
承上所述,本發明利用獲取篩檢者的呼出氣體進行預測,並在實測呼氣氨濃度大於呼氣氨濃度臨界值時,判斷該篩檢者疑似患有慢性腎臟病。相較於先前技術需要利用抽血等侵入性醫療行為所存在及衍生出的種種問題,本發明利用篩檢者的呼出氣體進行感測並做非侵入性的快速腎臟功能篩檢預測,能達到快速、方便、便宜地篩檢出須注意腎功能的篩檢者,進而達到早期慢性腎臟病的防治。此外,本發明也可以針對不同年齡的族群在呼氣氨濃度臨界值中定義出第一臨界值與第二臨界值,藉以針對不同年齡的族群達到相同的預測功效。Based on the above, the present invention uses the acquired exhaled gas of the screener for prediction, and when the measured exhaled ammonia concentration is greater than the threshold value of exhaled ammonia concentration, it is determined that the screener is suspected of suffering from chronic kidney disease. Compared with the existing and derived problems of the prior art requiring the use of invasive medical behaviors such as blood drawing, the present invention utilizes the exhaled gas of the screener for sensing and non-invasive rapid kidney function screening prediction, which can achieve Quickly, conveniently and inexpensively screen out those who need to pay attention to renal function, so as to prevent and treat early chronic kidney disease. In addition, the present invention can also define a first threshold value and a second threshold value in the threshold value of exhaled ammonia concentration for groups of different ages, so as to achieve the same prediction effect for groups of different ages.
下面將結合示意圖對本發明的具體實施方式進行更詳細的描述。根據下列描述和申請專利範圍,本發明的優點和特徵將更清楚。需說明的是,圖式均採用非常簡化的形式且均使用非精準的比例,僅用以方便、明晰地輔助說明本發明實施例的目的。The specific embodiments of the present invention will be described in more detail below with reference to the schematic diagrams. The advantages and features of the present invention will become more apparent from the following description and the scope of the claims. It should be noted that the drawings are all in a very simplified form and use inaccurate scales, and are only used to facilitate and clearly assist the purpose of explaining the embodiments of the present invention.
請參閱第一圖至第二B圖,其中,第一圖係顯示本發明較佳實施例所提供之慢性腎臟病預測系統之方塊圖;以及,第二A圖與第二B圖係顯示本發明較佳實施例所提供之慢性腎臟病預測方法之流程圖。一種慢性腎臟病預測方法包含以下步驟S101至S113。一種慢性腎臟病預測系統1可以用來實施上述慢性腎臟病預測方法,並包含一資料庫11、一獲取模組12、一氨感測模組13、一比較模組14與一預警模組15。Please refer to the first to the second B, wherein the first is a block diagram showing the chronic kidney disease prediction system provided by the preferred embodiment of the present invention; and, the second A and the second B are the The flow chart of the method for predicting chronic kidney disease provided by the preferred embodiment of the invention. A method for predicting chronic kidney disease includes the following steps S101 to S113. A chronic kidney
步驟S101:接收已受測者之已測呼氣氨濃度與腎臟病診斷結果。Step S101 : Receive the measured breath ammonia concentration and the diagnosis result of kidney disease of the tested subject.
步驟S102:設定一預設臨界值,將已測呼氣氨濃度與預設呼氣氨濃度臨界值進行比對,產生複數個腎臟病預測結果。Step S102: Set a preset threshold value, compare the measured breath ammonia concentration with the preset breath ammonia concentration threshold value, and generate a plurality of kidney disease prediction results.
步驟S103:將腎臟病預測結果與腎臟病診斷結果進行比對,藉以統計出以預設臨界值為判斷基準下之敏感性與特異性。Step S103 : Comparing the kidney disease prediction result with the kidney disease diagnosis result, so as to calculate the sensitivity and specificity based on the predetermined threshold value.
步驟S104:調整預設臨界值,重複執行上述步驟。Step S104: Adjust the preset threshold value, and repeat the above steps.
步驟S105:在敏感性與特異性達到可接受條件時,將預設臨界值定義為呼氣氨濃度臨界值。Step S105 : when the sensitivity and specificity reach acceptable conditions, define the preset threshold value as the threshold value of exhaled ammonia concentration.
資料庫11儲存有一預測規則,且預測規則中係定義出至少一呼氣氨濃度臨界值。The
步驟S106:獲取篩檢者的呼出氣體。Step S106: Obtain the exhaled breath of the screener.
獲取模組12獲取一篩檢者的一呼出氣體。The obtaining
獲取模組12可以包含一第一管路、一泵浦、一乾燥筒、一第二管路與一容器。泵浦使呼出氣體經由第一管路進入乾燥筒,並藉由乾燥筒乾燥呼出氣體。接著,泵浦使呼出氣體經由第二管路進入容器,而受容器所容置,但不以此為限。在本發明其他實施例中,獲取模組12也可以包含其他可以獲取篩檢者呼出氣體的元件或裝置。The
步驟S107:利用氨感測模組感測呼出氣體的實測呼氣氨濃度。Step S107 : use the ammonia sensing module to sense the measured exhaled ammonia concentration of exhaled air.
氨感測模組13用以感測呼出氣體的一實測呼氣氨濃度。氨感測模組13可以是感測晶片、感測裝置或是其他可以感測出氨濃度的模組。The
在本實施例中,獲取模組12還可以包含一第三管路。在氨感測模組13感測出實測呼氣氨濃度後,泵浦會使呼出氣體自容器經由第三管路輸送出。In this embodiment, the
步驟S108:將實測呼氣氨濃度與呼氣氨濃度臨界值進行比對。Step S108: Compare the measured exhaled ammonia concentration with the threshold value of exhaled ammonia concentration.
步驟S109:實測呼氣氨濃度是否大於呼氣氨濃度臨界值。Step S109: Whether the measured breath ammonia concentration is greater than the threshold value of breath ammonia concentration.
比較模組14電性連接資料庫11與氨感測模組13,用以比較實測呼氣氨濃度與呼氣氨濃度臨界值,並在實測呼氣氨濃度大於呼氣氨濃度臨界值時,判斷符合預測規則。The
在步驟S109判斷為是時,係進入步驟S110;並在步驟S109判斷為否時,進入步驟S112。When it is judged as YES in step S109, it goes to step S110; and when it is judged as NO in step S109, it goes to step S112.
步驟S110:產生預警資訊,且預警資訊代表篩檢者的初篩結果為疑似患有慢性腎臟病。Step S110 : generating early warning information, and the warning information represents that the preliminary screening result of the screening person is suspected of suffering from chronic kidney disease.
步驟S111:利用顯示模組顯示預警資訊。Step S111 : display the warning information by using the display module.
在本實施例中,慢性腎臟病預測系統1更包含一顯示模組16。顯示模組用以顯示預警資訊,其中,預警資訊係代表篩檢者的一初篩結果為疑似患有慢性腎臟病。因此,本發明可以利用呼氣的非侵入性醫療行為,達到篩檢預測篩檢者疑似患有慢性腎臟病的功效,進而達到慢性腎臟病的早期防治。In this embodiment, the chronic kidney
步驟S112:產生比對資訊,且比對資訊代表篩檢者的比對結果。Step S112: Generate matching information, and the matching information represents the matching result of the screener.
步驟S113:利用顯示模組顯示比對資訊。Step S113: Display the comparison information by using the display module.
此外,在本實施例中,慢性腎臟病預測系統1更包含一資訊產生模組17。資訊產生模組17係在實測呼氣氨濃度沒有大於呼氣氨濃度臨界值時,產生比對資訊,其中,比對資訊代表篩檢者的實測呼氣氨濃度與呼氣氨濃度臨界值的比對結果,並可以藉由顯示模組16顯示。因此,在篩檢者的初篩結果並非疑似患有慢性腎臟病的情況下,也可以讓篩檢者知道其實測呼氣氨濃度與呼氣氨濃度臨界值之間的關係。當顯示實測呼氣氨濃度與呼氣氨濃度臨界值很接近時,也可以讓篩檢者自行得到警惕。In addition, in this embodiment, the chronic kidney
接著,請一併參閱第一圖至第六圖;其中,第三圖係顯示已測呼氣氨濃度與血中尿素氨濃度的圖表;第四圖係顯示已測呼氣氨濃度與血清肌酸酐濃度的圖表;第五圖係顯示已測呼氣氨濃度與估算腎絲球過濾率的圖表;第六圖係顯示已測呼氣氨濃度與慢性腎臟病不同期別的比較圖表。如圖所示,資料庫11係包含一接收單元111、一設定單元112、一第一比對單元113、一第二比對單元114、一統計單元115、一定義單元116與一儲存單元117。Next, please refer to the first to sixth figures together; the third figure is a graph showing the measured breath ammonia concentration and blood urea ammonia concentration; the fourth figure shows the measured breath ammonia concentration and serum muscle concentration The graph of acid anhydride concentration; the fifth graph is a graph showing the measured exhaled ammonia concentration and the estimated glomerular filtration rate; the sixth graph is a graph showing the comparison of the measured exhaled ammonia concentration and different stages of chronic kidney disease. As shown in the figure, the
接收單元111會接收複數個已受測者的複數個已測呼氣氨濃度與複數個腎臟病診斷結果。腎臟病診斷結果通常包含已受測者的血中尿素氨(Blood Urea Nitrogen;BUN)濃度、血清肌酸酐(serum creatinine)濃度、估算腎絲球過濾率(estimated Glomerular Filtration Rate;eGFR)、年齡、性別等資訊。The receiving
目前最被廣泛應用及接受腎功能的指標是腎絲球過濾率(Glomerular Filtration Rate;GFR),臨床上會利用血清肌酸酐濃度依據公式導出估算腎絲球過濾率,因此,血清肌酸酐濃度與腎絲球過濾率或是估算腎絲球過濾率都有相關。另外,隨著腎功能變差,血中尿素氨濃度也會隨之上升。At present, the most widely used and accepted indicator of renal function is the glomerular filtration rate (GFR). Either the glomerular filtration rate or the estimated glomerular filtration rate is relevant. In addition, with the deterioration of renal function, the concentration of urea ammonia in the blood will also increase.
慢性腎臟病依據估算腎絲球過濾率分為五期,eGFR大於90mL/min為第一期;eGFR介於60到90mL/min之間為第二期;eGFR介於30到60mL/min之間為第三期;eGFR介於15到30mL/min之間為第四期;eGFR小於15mL/min為第五期。Chronic kidney disease is divided into five stages based on estimated glomerular filtration rate, with eGFR greater than 90 mL/min as the first stage; eGFR between 60 and 90 mL/min as the second stage; eGFR between 30 and 60 mL/
本案發明人收集多位已受測者的已測呼氣氨濃度與腎臟病診斷結果,其中,已受測者中包含慢性腎臟病第一期至第五期的患者。The inventors of the present application collected the measured breath ammonia concentration and the diagnosis results of kidney disease of a plurality of subjects, wherein the subjects included patients with chronic kidney disease stage I to stage V.
從第三圖可以明顯看出,已受測者的已測呼氣氨濃度和血中尿素氨濃度有很好的正相關性,其中,以統計學的觀點來看,第三圖的已測呼氣氨濃度和血中尿素氨濃度,R=0.723,p<0.001。It can be clearly seen from the third figure that there is a good positive correlation between the measured breath ammonia concentration and the blood urea ammonia concentration. Breath ammonia concentration and blood urea ammonia concentration, R=0.723, p<0.001.
從第四圖可以明顯看出已受測者的已測呼氣氨濃度和血清肌酸酐濃度也有很好的正相關性,其中,以統計學的觀點來看,第四圖的已測呼氣氨濃度和血清肌酸酐濃度,R=0.735,P<0.001。It can be clearly seen from the fourth figure that the measured breath ammonia concentration and serum creatinine concentration also have a good positive correlation. Among them, from a statistical point of view, the measured breath in the fourth figure Ammonia concentration and serum creatinine concentration, R=0.735, P<0.001.
因此,發明人從目前最被廣泛應用及接受腎功能的指標、第三圖與第四圖推論出,已測呼氣氨濃度也會與eGFR有相關,且應為良好的負相關性。而從第五圖的統計圖表可以明顯看出,已受測者的已測呼氣氨濃度和eGFR確實有負相關性,其中,以統計學的觀點來看,第五圖的已測呼氣氨濃度和eGFR,R=-0.535,p<0.001。因此,發明人對於已測呼氣氨濃度會與eGFR有相關的推論得到證實。Therefore, the inventor deduced from the most widely used and accepted indicators of renal function, the third and fourth figures, that the measured exhaled ammonia concentration will also be related to eGFR, and it should be a good negative correlation. From the statistical chart in Figure 5, it can be clearly seen that there is indeed a negative correlation between the measured breath ammonia concentration and eGFR of the tested subjects. From a statistical point of view, the measured breath in Figure 5 Ammonia concentration and eGFR, R=-0.535, p<0.001. Therefore, the inventor's inference that the measured breath ammonia concentration would be related to eGFR was confirmed.
另外,從第六圖可以看出,發明人根據已受測者的慢性腎臟病的期別,也可以明顯看出隨著慢性腎臟病的期別增加,已受測者的已測呼氣氨濃度皆有明顯的增加。以統計學的觀點來看,每一期的已測呼氣氨濃度和前一期的已測呼氣氨濃度比較起來,有統計意義地增加,其中,第六圖中的符號意義為:*表示p<0.05,**表示p<0.01,***表示p<0.001,****表示p<0.0001。In addition, as can be seen from the sixth figure, the inventor can also clearly see that with the increase of the stage of chronic kidney disease, the measured breath ammonia of the tested subjects increases according to the stage of chronic kidney disease of the tested subjects. The concentrations were significantly increased. From a statistical point of view, the measured expiratory ammonia concentration of each period is compared with the measured exhaled ammonia concentration of the previous period, and there is a statistically significant increase, among which, the meaning of the symbols in the sixth figure is: * means p<0.05, ** means p<0.01, *** means p<0.001, **** means p<0.0001.
接著,請一併參閱第一圖、第二圖、第七圖與第八圖,其中,第七圖係顯示預設臨界值於974ppb來區別第一期與第二至五期之ROC曲線圖;以及,第八圖係顯示預設臨界值於1187ppb來區別eGFR<60mL/min之ROC曲線圖。Next, please refer to Figure 1, Figure 2, Figure 7 and Figure 8 together, where Figure 7 shows the ROC curve of the first phase and the second to fifth phases by showing the default threshold at 974ppb And, the eighth figure is a ROC curve graph showing a preset threshold value of 1187ppb to distinguish eGFR<60mL/min.
發明人利用受試者操作特徵曲線(Receiver operating characteristic;ROC)來找出可以區分慢性腎臟病期別的值,並發現預設臨界值為974ppb來區別慢性腎臟病第一期與第二至五期病人時,曲線下面積(Area Under Curve;AUC)為最大,其中,AUC=0.835,p<0.0001。此時,敏感性有69%,特異性可達95%,陽性預測率為0.99,陰性預測率為0.36。The inventors used the receiver operating characteristic curve (Receiver operating characteristic; ROC) to find out the value that can distinguish the stage of chronic kidney disease, and found that the preset threshold value is 974ppb to distinguish the first stage of chronic kidney disease from the second to fifth stage. The area under the curve (AUC) was the largest in patients with
而隨著年齡增加,腎功能也會逐漸下降,故臨床實際應用會定義慢性腎臟病為eGFR<60mL/min,因此,發明人還利用受試者操作特徵曲線(Receiver operating characteristic;ROC)來找出可以區分eGFR<60mL/min的值,並發現預設臨界值為1187ppb來區別是否患者eGFR<60mL/min時,曲線下面積(Area Under Curve;AUC)為最大,其中,AUC=0.831,p<0.0001。此時,敏感性有71%,特異性可達78%,陽性預測率為0.84,陰性預測率為0.61。With the increase of age, renal function will gradually decline, so the clinical application will define chronic kidney disease as eGFR<60mL/min. Therefore, the inventor also uses the receiver operating characteristic curve (Receiver operating characteristic; ROC) to find The value that can distinguish eGFR<60mL/min, and found that the preset critical value is 1187ppb to distinguish whether the patient eGFR<60mL/min, the area under the curve (Area Under Curve; AUC) is the largest, where, AUC=0.831, p <0.0001. At this time, the sensitivity was 71%, the specificity was 78%, the positive predictive rate was 0.84, and the negative predictive rate was 0.61.
因此,從第七圖與第八圖可以再次證實,已受測者的已測呼氣氨濃度會與已受測者的腎功能有明顯相關性。Therefore, it can be confirmed again from the seventh figure and the eighth figure that the measured exhaled ammonia concentration of the subject has a significant correlation with the renal function of the subject.
設定單元112用以設定與調整一預設臨界值,也就是說,設定單元112會不斷調整預設臨界值,本案發明人將預設臨界值自680ppb調整至1246ppb。The
第一比對單元113電性連接接收單元111與設定單元112,將已測呼氣氨濃度與預設臨界值進行比對,而產生複數個腎臟病預測結果。The first comparing
第二比對單元114電性連接接收單元111與設定單元112,用以將腎臟病預測結果與腎臟病診斷結果進行比對。The second comparing
統計單元115電性連接第二比對單元114,藉以統計出以該預設臨界值為判斷基準下的一敏感性(Sensitivity)與一特異性(Specificity)。The
定義單元116電性連接統計單元115,用以在敏感性與特異性達到一可接受條件時,將當時的預設臨界值定義為預測規則中的呼氣氨濃度臨界值。當有多個預設臨界值的敏感性與特異性達到可接受條件時,定義單元116便會分別定義為呼氣氨濃度臨界值中的一第一臨界值與一第二臨界值。在本實施例中,可接受條件是敏感性與特異性所形成的ROC曲線的AUC值最大,也就是敏感性加特異性之總和的最大值,但不以此為限,也可以是AUC值大於特定數值、或是敏感性大於特定百分比、特異性大於特定百分比、敏感性加上特異性的百分比大於特定百分比等其他條件。The defining
可參閱下表一,表一為設定單元112設定與調整不同預設臨界值後,統計單元115統計出eGFR<60mL/min的敏感性與特異性。
因為不同的預設臨界值都有敏感性與特異性。當提高敏感性時,特異性就會下降。在盛行率高的族群,偽陽性會較低。因此,在無立即危險性的慢性腎臟病的篩檢中,可以減少敏感性來增加特異性,因而減少偽陽性。因此,本發明經過上述調整預設臨界值的統計結果後,定義單元116係定義出呼氣氨濃度臨界值中之一第一臨界值為886ppb,此時,敏感性>80%。在所屬技術領域的通常知識中,對於非致命性疾病篩檢的敏感度達到80%,即被認為是可接受的篩檢方法或篩檢工具。Because different preset cutoff values have sensitivity and specificity. As sensitivity increases, specificity decreases. In groups with high prevalence, false positives will be lower. Therefore, in screening for chronic kidney disease without immediate risk, sensitivity can be decreased to increase specificity, thereby reducing false positives. Therefore, according to the present invention, after the statistical result of adjusting the preset threshold value, the defining
當篩檢者的實測呼氣氨濃度大於呼氣氨濃度臨界值中的第一臨界值時,係判斷符合預測規則。因此,預警模組15便會產生預警資訊。在本實施例中,顯示模組16會顯示預警資訊供篩檢者或是相關人士觀看,但不以此為限。在本發明其他實施例中,也可以利用訊息等方式傳送預警資訊至篩檢者或是相關人士的手機供其觀看。When the measured exhaled ammonia concentration of the screener is greater than the first critical value in the expiratory ammonia concentration critical values, it is judged that the prediction rule is met. Therefore, the
較佳者,定義單元116係針對不同族群定義出呼氣氨濃度臨界值中的不同臨界值。舉例來說,因為隨著年齡增加,腎功能也會逐漸下降,故年長的族群當eGFR<60mL/min時,即應進一步進行檢驗與治療,而年輕的族群則是在eGFR<90mL/min時,便需要進一步進行檢驗與治療。因此,定義單元116可以定義出呼氣氨濃度臨界值中的一第一臨界值與一第二臨界值,其中,第一臨界值是針對年長的族群,第二臨界值是針對年輕的族群。在本實施例中,定義單元116係定義出第一臨界值為886ppb(敏感性為80%,特異性為69%),並定義出第二臨界值為974ppb(特異性為95%),其中,第一臨界值對應年長的族群的一第一年齡區間,第二臨界值對應年輕的族群的一第二年齡區間,且第一年齡區間的一第一年齡下限值會大於第二年齡區間的一第二年齡上限值。因此,本發明針對非立即有生命危險的慢性腎臟病的篩檢預測,有著高敏感性與高特異性。Preferably, the defining
儲存單元117電性連接定義單元116,用以儲存預測規則。比較模組14便會依據篩檢者的年齡,比較該實測呼氣氨濃度與篩檢者的年齡所對應到的臨界值(年長族群對應第一臨界值,年輕族群對應第二臨界值)。The
最後,請參閱第一圖、第二圖與第九圖,其中,第九圖係顯示本發明的實際篩檢預測結果圖表。發明人針對34位有意願的篩檢者,利用本發明進行篩檢預測,其中,篩檢者都屬於年長的族群。按照統計分析,樣本數大於30即具有代表性。Finally, please refer to the first figure, the second figure and the ninth figure, wherein the ninth figure is a graph showing the actual screening prediction result of the present invention. The inventors used the present invention to perform screening prediction for 34 willing screeners, wherein all the screeners belonged to the elderly group. According to statistical analysis, the number of samples greater than 30 is representative.
本發明按照前述方式定義出預測規則中的呼氣氨濃度臨界值,獲取34位篩檢者各自的呼出氣體,並且感測34位篩檢者的呼出氣體中的實測呼氣氨濃度。在比對實測呼氣氨濃度大於呼氣氨濃度臨界值的第一臨界值(886ppb)時,對該篩檢者產生預警資訊,預警資訊代表篩檢者的初篩結果為疑似患有慢性腎臟病。The present invention defines the threshold value of exhaled ammonia concentration in the prediction rule according to the aforementioned method, obtains the exhaled air of each of 34 screeners, and senses the measured exhaled ammonia concentration in the exhaled air of the 34 screeners. When the measured exhaled ammonia concentration is greater than the first critical value (886ppb) of the expiratory ammonia concentration threshold, an early warning message is generated for the screener, and the early warning message indicates that the screening result of the screener is suspected of having chronic kidney disease sick.
經本發明篩檢預測後,實測呼氣氨濃度大於886ppb的篩檢者有六位,表示本發明篩檢預測為疑似患有慢性腎臟病的篩檢者有六位。實際上,上述六位篩檢者各自的eGFR分別為21、49、49、54、79、82mL/min,其中,eGFR<60mL/min的篩檢者有四位,表示上述六位被本發明篩檢預測為疑似患有慢性腎臟病的六位篩檢者中,有四位篩檢者確實患有慢性腎臟病。而所有篩檢者中,eGFR<60mL/min的篩檢者也僅有上述四位,他們的實測呼氣氨濃度也確實都大於886ppb。表示上述四位需要立即進一步檢驗與治療的篩檢者都被本發明所篩檢出。After the screening test of the present invention predicts, there are six screeners whose expiratory ammonia concentration is greater than 886ppb, indicating that the screening test of the present invention predicts that there are six screeners who are suspected of suffering from chronic kidney disease. In fact, the eGFRs of the above six screeners were 21, 49, 49, 54, 79, and 82 mL/min, respectively. Among them, there were four screeners with eGFR < 60 mL/min, indicating that the above six were affected by the present invention. Of the six screeners whose screening predicted suspected CKD, four did have CKD. Among all the screeners, there are only the above four screeners with eGFR <60mL/min, and their measured exhaled ammonia concentrations are indeed greater than 886ppb. It means that the above four screeners who need immediate further examination and treatment are all screened out by the present invention.
從第九圖可以統計出,本發明對於eGFR<60mL/min,實測呼氣氨濃度大於886ppb,敏感性為100%(4/4),特異性為94%(29/31),陽性預測率為67%(4/6),陰性預測率為100%(29/29)。因此,經由上述篩檢預測,可以進一步證實本發明確實可以達到早期防治慢性腎臟病的功效。另外,基於所屬技術領域中的通常知識,第九圖也有利用粗黑線標示出實測呼氣氨濃度大於886ppb的六位篩檢者們與實測呼氣氨濃度小於886ppb的二十九位篩檢者們的eGFR的平均值。It can be calculated from the ninth figure that the present invention has a sensitivity of 100% (4/4) and a specificity of 94% (29/31) for eGFR<60mL/min and the measured exhaled ammonia concentration greater than 886ppb, with a positive predictive rate of 94% (29/31). was 67% (4/6), and the negative predictive rate was 100% (29/29). Therefore, through the above screening prediction, it can be further confirmed that the present invention can indeed achieve the effect of early prevention and treatment of chronic kidney disease. In addition, based on common knowledge in the technical field, Figure 9 also uses thick black lines to indicate six screeners whose measured breath ammonia concentration is greater than 886ppb and twenty-nine screeners whose measured breath ammonia concentration is less than 886ppb the mean of the eGFR of the participants.
綜上所述,本發明利用獲取篩檢者的呼出氣體進行預測,並在實測呼氣氨濃度大於呼氣氨濃度臨界值時,判斷該篩檢者疑似患有慢性腎臟病。相較於先前技術需要利用抽血等侵入性醫療行為所存在及衍生出的種種問題,本發明利用篩檢者的呼出氣體進行感測並做非侵入性的快速腎臟功能篩檢預測,能達到快速、方便、便宜地篩檢出須注意腎功能的篩檢者,進而達到早期慢性腎臟病的防治。此外,本發明也可以針對不同年齡的族群在呼氣氨濃度臨界值中定義出第一臨界值與第二臨界值,藉以針對不同年齡的族群達到相同的預測功效。To sum up, the present invention uses the acquired exhaled gas of the screener for prediction, and when the measured exhaled ammonia concentration is greater than the threshold value of exhaled ammonia concentration, it is determined that the screener is suspected of suffering from chronic kidney disease. Compared with the existing and derived problems of the prior art requiring the use of invasive medical behaviors such as blood drawing, the present invention utilizes the exhaled gas of the screener for sensing and non-invasive rapid kidney function screening prediction, which can achieve Quickly, conveniently and inexpensively screen out those who need to pay attention to renal function, so as to prevent and treat early chronic kidney disease. In addition, the present invention can also define a first threshold value and a second threshold value in the threshold value of exhaled ammonia concentration for groups of different ages, so as to achieve the same prediction effect for groups of different ages.
藉由以上較佳具體實施例之詳述,係希望能更加清楚描述本發明之特徵與精神,而並非以上述所揭露的較佳具體實施例來對本發明之範疇加以限制。相反地,其目的是希望能涵蓋各種改變及具相等性的安排於本發明所欲申請之專利範圍的範疇內。Through the detailed description of the preferred embodiments above, it is hoped that the features and spirit of the present invention can be described more clearly, and the scope of the present invention is not limited by the preferred embodiments disclosed above. On the contrary, the intention is to cover various modifications and equivalent arrangements within the scope of the claimed scope of the present invention.
1:慢性腎臟病預測系統 11:資料庫 111:接收單元 112:設定單元 113:第一比對單元 114:第二比對單元 115:統計單元 116:定義單元 117:儲存單元 12:獲取模組 13:氨感測模組 14:比較模組 15:預警模組 16:顯示模組 17:資訊產生模組 S101~S113:步驟 1: Chronic Kidney Disease Prediction System 11:Database 111: Receiver unit 112: Setting unit 113: The first comparison unit 114: Second comparison unit 115: Statistics Unit 116: Define Unit 117: Storage unit 12: Get mods 13: Ammonia sensing module 14: Compare Mods 15: Early warning module 16: Display module 17: Information generation module S101~S113: Steps
第一圖係顯示本發明較佳實施例所提供之慢性腎臟病預測系統之方塊圖; 第二A圖與第二B圖係顯示本發明較佳實施例所提供之慢性腎臟病預測方法之流程圖; 第三圖係顯示已測呼氣氨濃度與血中尿素氨濃度的圖表; 第四圖係顯示已測呼氣氨濃度與血清肌酸酐濃度的圖表; 第五圖係顯示已測呼氣氨濃度與估算腎絲球過濾率的圖表; 第六圖係顯示已測呼氣氨濃度與慢性腎臟病不同期別的比較圖表; 第七圖係顯示預設臨界值於974ppb來區別第一期與第二至五期之ROC曲線圖; 第八圖係顯示預設臨界值於1187ppb來區別eGFR<60mL/min之ROC曲線圖;以及 第九圖係顯示本發明的實際篩檢預測結果圖表。 The first figure is a block diagram showing the chronic kidney disease prediction system provided by the preferred embodiment of the present invention; The second A and the second B are flowcharts showing the method for predicting chronic kidney disease provided by the preferred embodiment of the present invention; The third figure is a graph showing the measured breath ammonia concentration and blood urea ammonia concentration; The fourth panel is a graph showing the measured breath ammonia concentration and serum creatinine concentration; The fifth figure is a graph showing measured exhaled ammonia concentration and estimated glomerular filtration rate; The sixth figure is a graph showing the comparison of measured breath ammonia concentration and chronic kidney disease in different stages; Figure 7 shows the ROC curves of the first phase and the second to fifth phases with a preset threshold of 974ppb; The eighth figure is a ROC curve graph showing the preset threshold at 1187ppb to distinguish eGFR<60mL/min; and The ninth figure is a graph showing the actual screening prediction results of the present invention.
S101~S113:步驟 S101~S113: Steps
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110140212A TWI777833B (en) | 2021-10-29 | 2021-10-29 | Method of predicting chronic kidney disease and system thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110140212A TWI777833B (en) | 2021-10-29 | 2021-10-29 | Method of predicting chronic kidney disease and system thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI777833B true TWI777833B (en) | 2022-09-11 |
TW202318442A TW202318442A (en) | 2023-05-01 |
Family
ID=84958214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110140212A TWI777833B (en) | 2021-10-29 | 2021-10-29 | Method of predicting chronic kidney disease and system thereof |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI777833B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201721139A (en) * | 2015-12-11 | 2017-06-16 | 台灣奈米碳素股份有限公司 | Medical ventilator capable of analyzing infection and bacteria of pneumonia via gas identification |
TWI705412B (en) * | 2019-03-22 | 2020-09-21 | 台灣奈米碳素股份有限公司 | System for evaluating flavor of food based on its releasing gas |
-
2021
- 2021-10-29 TW TW110140212A patent/TWI777833B/en active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201721139A (en) * | 2015-12-11 | 2017-06-16 | 台灣奈米碳素股份有限公司 | Medical ventilator capable of analyzing infection and bacteria of pneumonia via gas identification |
TWI705412B (en) * | 2019-03-22 | 2020-09-21 | 台灣奈米碳素股份有限公司 | System for evaluating flavor of food based on its releasing gas |
Non-Patent Citations (1)
Title |
---|
期刊 吳宗正, 吳政穎, 林于生, 許品超, 施錫璋 非侵入式呼氣輔助疾病診斷生醫感測器之開發與應用 科儀新知 第28卷第4期 科儀新知 2007 16~27 * |
Also Published As
Publication number | Publication date |
---|---|
TW202318442A (en) | 2023-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stockley et al. | Small airways disease: time for a revisit? | |
Jain et al. | Quantitative computed tomography detects peripheral airway disease in asthmatic children | |
Lowe et al. | Reported versus confirmed wheeze and lung function in early life | |
Lemiere et al. | Diagnosing occupational asthma: use of induced sputum | |
Girard et al. | An effective strategy for diagnosing occupational asthma: use of induced sputum | |
US20110009764A1 (en) | Devices, systems, and methods for aiding in the detection of a physiological abnormality | |
Syrjala et al. | Chest magnetic resonance imaging for pneumonia diagnosis in outpatients with lower respiratory tract infection | |
EP2344035A1 (en) | Oral end tidal carbon dioxide probe | |
JP2006068533A (en) | Lung function diagnostic device using ultrasound and lung function diagnostic method using the same | |
Oliveira et al. | Assessment of respiratory muscle weakness in subjects with neuromuscular disease | |
US20140038300A1 (en) | Devices, Systems, and Methods for Aiding in the Detection of a Physiological Abnormality | |
TWI755108B (en) | Method for assessing acute kidney injury and acute kidney injury assessment system | |
Imamura et al. | Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis | |
Yune et al. | Fractional exhaled nitric oxide: comparison between portable devices and correlation with sputum eosinophils | |
Veneroni et al. | Diagnostic potential of oscillometry: a population-based approach | |
TWI777833B (en) | Method of predicting chronic kidney disease and system thereof | |
Ten Broeke et al. | The Roth score as a triage tool for detecting hypoxaemia in general practice: a diagnostic validation study in patients with possible COVID-19 | |
Kim et al. | Reference ranges for induced sputum eosinophil counts in Korean adult population | |
Jason et al. | Sensitivity and specificity of the CDC empirical chronic fatigue syndrome case definition | |
Rate | Epidemiology & Biostatistics | |
Singh et al. | Assessment of newly developed real-time human respiration carbon dioxide measurement device for management of asthma outside of hospital | |
Crapo | Role of reference values in making medical decisions | |
Pipavath et al. | High resolution CT (HRCT) in miliary tuberculosis (MTB) of the lung: correlation with pulmonary function tests & gas exchange parameters in north Indian patients | |
Lutfi | Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma | |
Alhassan et al. | Defining accelerometer thresholds for physical activity in girls using ROC analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent |